Clinical Trials Browser

Anus Neoplasms, Urinary Bladder Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Flatulence, Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Rectal Neoplasms

NCT05605964 2025-08-17

Randomized Study to Evaluate MACE in Patients With Prostate Cancer Treated With Relugolix or Leuprolide Acetate

Phase 3 Completed

387 enrolled

Genitourinary

Prostatic Neoplasms

NCT03834506 2025-07-18

KEYNOTE-921

Phase 3 Completed

1,030 enrolled 24 charts

Genitourinary

Parkinson Disease 4, Autosomal Dominant Lewy Body, Prostatic Neoplasms

NCT05547386 2025-07-18

68Ga-PSMA-11 PET/CT Screening Prior to 177Lu-PSMA-617 Therapy for Patients With Metastatic Castrate Resistant Prostate Cancer

Phase 3 Completed

163 enrolled 3 charts

Genitourinary

Prostatic Neoplasms

NCT04742361 2025-07-15

Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate Cancer

Phase 3 Completed

136 enrolled

Genitourinary

Prostatic Neoplasms

NCT04100018 2025-06-12

CheckMate 7DX

Phase 3 Completed

1,030 enrolled 25 charts

Genitourinary

Prostatic Neoplasms

NCT03072238 2025-06-06

IPATential150

Phase 3 Completed

1,101 enrolled 35 charts

Genitourinary

Prostatic Neoplasms

NCT00667069 2025-06-05

Triptorelin and Radiation Therapy in Treating Patients Who Have Undergone Surgery for Intermediate-Risk Stage III or Stage IV Prostate Cancer

Phase 3 Completed

424 enrolled

Genitourinary

Prostatic Neoplasms

NCT03834519 2025-05-18

KEYLYNK-010

Phase 3 Completed

793 enrolled 23 charts

Genitourinary

Parkinson Disease 4, Autosomal Dominant Lewy Body, Prostatic Neoplasms

NCT01220869 2025-04-13

A Study of Degarelix in Taiwanese Patients With Prostate Cancer

Phase 3 Completed

110 enrolled 11 charts

Genitourinary

Prostatic Neoplasms

NCT02288247 2025-04-08

PRESIDE

Phase 3 Completed

688 enrolled 13 charts

Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

NCT04186819 2025-02-26

Imaging Study to Investigate the Safety and Diagnostic Performance of rhPSMA 7.3 (18F) in Newly Diagnosed Prostate Cancer.

Phase 3 Completed

356 enrolled 28 charts

Genitourinary

Disease, Prostatic Neoplasms

NCT02043678 2025-02-19

ERA 223

Phase 3 Completed

806 enrolled 32 charts

Genitourinary

Prostatic Neoplasms

NCT00887198 2025-02-04

Abiraterone Acetate in Asymptomatic or Mildly Symptomatic Patients With Metastatic Castration-Resistant Prostate Cancer

Phase 3 Completed

1,088 enrolled 14 charts

Genitourinary

Prostatic Neoplasms

NCT01715285 2025-02-04

A Study of Abiraterone Acetate Plus Low-Dose Prednisone Plus Androgen Deprivation Therapy (ADT) Versus ADT Alone in Newly Diagnosed Participants With High-Risk, Metastatic Hormone-Naive Prostate Cancer (mHNPC)

Phase 3 Completed

1,209 enrolled 16 charts 1 FDA

Genitourinary

Prostatic Neoplasms

NCT03511664 2025-01-13

VISION

Phase 3 Completed

861 enrolled 39 charts 1 FDA

Genitourinary

Prostatic Neoplasms

NCT02220829 2024-12-09

Comparative Study of Use of Alpha-Blockers to Treat Symptoms in Prostate Cancer Patients Undergoing Radiation Therapy

Phase 3 Completed

148 enrolled

Genitourinary

Prostatic Neoplasms

NCT01964170 2024-10-31

A Study to Compare the Effect of ASP3550 With Goserelin in Patients With Prostate Cancer

Phase 3 Completed

234 enrolled

Genitourinary

Prostatic Neoplasms

NCT01272050 2024-08-28

Radiation Therapy in Treating Patients With Relapsed Prostate Cancer After Surgery

Phase 3 Completed

350 enrolled

Genitourinary

Prostatic Neoplasms

NCT04887506 2024-01-16

TAVT-45 (Abiraterone Acetate) Granules in Patients With Prostate Cancer

Phase 3 Completed

107 enrolled 20 charts

Genitourinary

Neoplasm Metastasis, Neoplasms, Prostatic Neoplasms

NCT01394263 2024-01-02

Study of Histrelin Subdermal Implant in Patients With Prostate Cancer

Phase 3 Completed

59 enrolled

Genitourinary

Prostatic Neoplasms

NCT01697384 2024-01-02

Study to Evaluate Efficacy and Safety of Histrelin Subdermal Implant in Men With Advanced Prostate Cancer

Phase 3 Completed

138 enrolled

GenitourinaryHead & Neck

Salivary Gland Adenoma, Pleomorphic, Prostatic Neoplasms

NCT03001869 2023-11-27

68Ga-PSMA PET/CT in Prostate Cancer

Phase 3 Completed

540 enrolled

Genitourinary

Prostatic Neoplasms

NCT00541047 2023-11-13

RADICALS - Radiotherapy and Androgen Deprivation In Combination After Local Surgery

Phase 3 Completed

4,236 enrolled

GenitourinaryOther

Prostatic Neoplasms, Sexual Dysfunction, Physiological

NCT00942331 2023-10-16

Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer

Phase 3 Completed

506 enrolled 13 charts

Genitourinary

Carcinoma, Transitional Cell, Prostatic Neoplasms, Ureteral Neoplasms, Urethral Neoplasms

NCT00664456 2023-07-24

SHIP0804

Phase 3 Completed

421 enrolled

Genitourinary

Prostatic Neoplasms

NCT02015871 2023-06-18

PandaExtension

Phase 3 Completed

206 enrolled

Genitourinary

Prostatic Neoplasms

NCT00027859 2023-06-15

Hormone Therapy Compared With Combination Chemotherapy in Treating Patients With Prostate Cancer

Phase 3 Completed

Genitourinary

Prostatic Neoplasms

NCT00060398 2023-06-15

Epoetin Alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer

Phase 3 Completed

282 enrolled

Classical hematologyGenitourinary

Anemia, Fatigue, Prostatic Neoplasms

NCT02659527 2023-06-15

PET/MRI in Patients With Suspected Prostate Cancer

Phase 3 Completed

220 enrolled

Genitourinary

Prostatic Neoplasms

NCT01238172 2023-03-21

Diet in Altering Disease Progression in Patients With Prostate Cancer on Active Surveillance

Phase 3 Completed

478 enrolled 11 charts

Genitourinary

Prostatic Neoplasms

NCT04854993 2023-01-25

RECIR

Phase 3 Completed

34 enrolled

Genitourinary

Prostatic Neoplasms

NCT00033631 2023-01-18

Radiation Therapy in Treating Patients With Stage II Prostate Cancer

Phase 3 Completed

1,534 enrolled 14 charts

Genitourinary

Prostatic Neoplasms

NCT00055731 2023-01-18

Hormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is Locally Advanced or At High Risk of Relapse

Phase 3 Completed

413 enrolled

Genitourinary

Prostatic Neoplasms

NCT00004124 2022-12-30

S9921, Hormone Therapy With or Without Mitoxantrone and Prednisone in Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer

Phase 3 Completed

983 enrolled 13 charts

Genitourinary

Prostatic Neoplasms

NCT05614518 2022-11-14

Diagnostic Performance and Safety of 18F-NaF-PET/CT in Bone Metastases Compared With 99mTc⁃MDP-BS±SPECT

Phase 3 Completed

280 enrolled

BreastGenitourinaryThoracic

Breast Neoplasms, Lung Neoplasms, Prostatic Neoplasms

NCT00377156 2022-09-16

Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases

Phase 3 Completed

213 enrolled 16 charts

BreastCNSGenitourinaryThoracic

Brain Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis, Prostatic Neoplasms, Breast Neoplasms, Male

NCT00288080 2022-06-21

Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer

Phase 3 Completed

612 enrolled 11 charts

Genitourinary

Prostatic Neoplasms

NCT02352103 2022-02-25

Impact of Robot-assisted Radical Prostatectomy Technique on Short-term Continence Recovery

Phase 3 Completed

120 enrolled 14 charts

Genitourinary

Prostatic Neoplasms, Urinary Incontinence

NCT03085095 2022-01-18

HERO

Phase 3 Completed

1,134 enrolled 38 charts 2 FDA

Genitourinary

Prostatic Neoplasms